CIK 0001726445
- Non-accelerated filer
- Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821153150
- Phone
- +1 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- 4 Grant or award Director acquired 46,886 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 12,109 shares at $1.78 ($21,512)
- 4 Grant or award Director acquired 58,178 shares (grant or award)
- 4 Grant or award Director acquired 58,178 shares (grant or award)
- 4 Grant or award Director acquired 58,178 shares (grant or award)
- 4 Grant or award Director acquired 58,178 shares (grant or award)
- 4 Grant or award Director acquired 58,178 shares (grant or award)
- 4 Grant or award Director acquired 58,178 shares (grant or award)
- 4 Open-market sale CEO AND CHAIR sold 52,857 shares at $2.03 ($107,421)
- 4 Open-market sale CHIEF LEGAL OFFICER sold 12,684 shares at $1.58 ($20,024)
- 4 Open-market sale PRESIDENT & CFO sold 12,684 shares at $1.58 ($20,024)
- 4 Grant or award CEO AND CHAIR acquired 529,634 shares (grant or award)
- 4 Open-market sale President and CFO sold 3,608 shares at $1.67 ($6,015)
- 4 Open-market sale Chief Legal Officer sold 8,182 shares at $1.70 ($13,869)
- 4 Exercise or conversion CEO, President and Chair acquired 151,764 shares (option exercise)
- 4 Open-market buy CEO, President and Chair bought 40,000 shares at $2.45 ($97,968)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
Page 3 of 9 · 166 filings